Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Time to Rethink Our Strategy With a Preoperative Intensification Approach.

Saba NF.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):762. doi: 10.1016/j.ijrobp.2018.03.050. Epub 2018 Jun 20. No abstract available.

PMID:
29976483
2.

Radiographic Imaging Does Not Reliably Predict Macroscopic Extranodal Extension in Human Papilloma Virus-Associated Oropharyngeal Cancer.

Patel MR, Hudgins PA, Beitler JJ, Magliocca KR, Griffith CC, Liu Y, Bougnon K, El-Deiry M, Saba NF, Aiken AH.

ORL J Otorhinolaryngol Relat Spec. 2018 Jul 3;80(2):85-95. doi: 10.1159/000487239. [Epub ahead of print]

PMID:
29969771
3.

Prognosis of subglottic carcinoma: Is it really worse?

Coskun H, Mendenhall WM, Rinaldo A, Rodrigo JP, Suárez C, Strojan P, López F, Mondin V, Saba NF, Shaha AR, Smee R, Takes RP, Ferlito A.

Head Neck. 2018 Jun 26. doi: 10.1002/hed.25172. [Epub ahead of print] Review.

PMID:
29947111
4.

Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical Trial.

Ferris RL, Saba NF, Gitlitz BJ, Haddad R, Sukari A, Neupane P, Morris JC, Misiukiewicz K, Bauman JE, Fenton M, Jimeno A, Adkins DR, Schneider CJ, Sacco AG, Shirai K, Bowles DW, Gibson M, Nwizu T, Gottardo R, Manjarrez KL, Dietsch GN, Bryan JK, Hershberg RM, Cohen EEW.

JAMA Oncol. 2018 Jun 21. doi: 10.1001/jamaoncol.2018.1888. [Epub ahead of print]

PMID:
29931076
5.

Systemic therapy in non-conventional cancers of the larynx.

Tan E, Mody MD, Saba NF.

Oral Oncol. 2018 Jul;82:61-68. doi: 10.1016/j.oraloncology.2018.05.005. Epub 2018 May 26. Review.

PMID:
29909903
6.

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.

Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington KJ, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Docampo LCI, Haddad R, Rordorf T, Kiyota N, Tahara M, Lynch M, Jayaprakash V, Li L, Gillison ML.

Oral Oncol. 2018 Jun;81:45-51. doi: 10.1016/j.oraloncology.2018.04.008. Epub 2018 Apr 17.

PMID:
29884413
7.

CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.

Gillison ML, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington KJ, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Li L, Ferris RL.

Oncologist. 2018 Jun 4. pii: theoncologist.2017-0674. doi: 10.1634/theoncologist.2017-0674. [Epub ahead of print]

PMID:
29866947
8.

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era.

Robinson HR, Qi J, Cook EM, Nichols C, Dadashian EL, Underbayev C, Herman SEM, Saba NS, Keyvanfar K, Sun C, Ahn IE, Baskar S, Rader C, Wiestner A.

Blood. 2018 May 9. pii: blood-2018-02-830992. doi: 10.1182/blood-2018-02-830992. [Epub ahead of print]

PMID:
29743179
9.

Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer.

Xiao C, Beitler JJ, Higgins KA, Glazer T, Huynh LK, Paul S, Felger JC, Wommack EC, Saba NF, Shin DM, Bruner DW, Miller AH.

Cancer. 2018 May 9. doi: 10.1002/cncr.31537. [Epub ahead of print]

PMID:
29742284
10.

Preparation and characterization of nanocomposite films from oil palm pulp nanocellulose/poly (Vinyl alcohol) by casting method.

Asad M, Saba N, Asiri AM, Jawaid M, Indarti E, Wanrosli WD.

Carbohydr Polym. 2018 Jul 1;191:103-111. doi: 10.1016/j.carbpol.2018.03.015. Epub 2018 Mar 11.

PMID:
29661297
11.

Single-Nucleotide Polymorphisms of FAS and FASL Genes and Risk of Idiopathic Aplastic Anemia.

Rehman S, Saba N, Naz M, Ahmed P, Munir S, Sajjad S, Tabassum S, Naseem L.

Immunol Invest. 2018 Jul;47(5):484-491. doi: 10.1080/08820139.2018.1458106. Epub 2018 Apr 3.

PMID:
29611722
12.

Single nucleotide polymorphisms in asthma candidate genes TBXA2R, ADAM33 FCER1B and ORMDL3 in Pakistani asthmatics a case control study.

Saba N, Yusuf O, Rehman S, Munir S, Noor A, Saqlain M, Mansoor A, Raja GK.

Asthma Res Pract. 2018 Mar 22;4:4. doi: 10.1186/s40733-018-0039-4. eCollection 2018.

14.

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.

Ahn IE, Farooqui MZH, Tian X, Valdez J, Sun C, Soto S, Lotter J, Housel S, Stetler-Stevenson M, Yuan CM, Maric I, Calvo KR, Nierman P, Hughes TE, Saba NS, Marti GE, Pittaluga S, Herman SEM, Niemann CU, Pedersen LB, Geisler CH, Childs R, Aue G, Wiestner A.

Blood. 2018 May 24;131(21):2357-2366. doi: 10.1182/blood-2017-12-820910. Epub 2018 Feb 26.

PMID:
29483101
15.

A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma.

Steuer CE, Griffith CC, Nannapaneni S, Patel MR, Liu Y, Magliocca KR, El-Deiry MW, Cohen C, Owonikoko TK, Shin DM, Chen ZG, Saba NF.

Mol Cancer Ther. 2018 Mar;17(3):710-716. doi: 10.1158/1535-7163.MCT-17-0504. Epub 2018 Feb 13.

PMID:
29440293
16.

A Review of Photodynamic Therapy for Neoplasms of the Head and Neck.

Civantos FJ, Karakullukcu B, Biel M, Silver CE, Rinaldo A, Saba NF, Takes RP, Vander Poorten V, Ferlito A.

Adv Ther. 2018 Mar;35(3):324-340. doi: 10.1007/s12325-018-0659-3. Epub 2018 Feb 7. Review.

PMID:
29417455
17.

Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome.

Coca-Pelaz A, Takes RP, Hutcheson K, Saba NF, Haigentz M Jr, Bradford CR, de Bree R, Strojan P, Lund VJ, Mendenhall WM, Nixon IJ, Quer M, Rinaldo A, Ferlito A.

Adv Ther. 2018 Feb;35(2):153-160. doi: 10.1007/s12325-018-0663-7. Epub 2018 Feb 2. Review.

PMID:
29396681
18.

Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.

Wang X, Beitler JJ, Huang W, Chen G, Qian G, Magliocca K, Patel MR, Chen AY, Zhang J, Nannapaneni S, Kim S, Chen Z, Deng X, Saba NF, Chen ZG, Arbiser JL, Shin DM.

Clin Cancer Res. 2018 Feb 15;24(4):858-869. doi: 10.1158/1078-0432.CCR-17-0345. Epub 2017 Nov 27.

PMID:
29180609
19.

MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia.

Saba NS, Wong DH, Tanios G, Iyer JR, Lobelle-Rich P, Dadashian EL, Liu D, Fontan L, Flemington EK, Nichols CM, Underbayev C, Safah H, Melnick A, Wiestner A, Herman SEM.

Cancer Res. 2017 Dec 15;77(24):7038-7048. doi: 10.1158/0008-5472.CAN-17-2485. Epub 2017 Oct 9.

PMID:
28993409
20.

Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.

Zhang H, Kim S, Chen Z, Nannapaneni S, Chen AY, Moore CE, Sica G, Mosunjac M, Nguyen MLT, D'Souza G, Carey TE, Peterson LA, McHugh JB, Graham M, Komarck CM, Wolf GT, Walline HM, Bellile E, Riddell J 4th, Pai SI, Sidransky D, Westra WH, William WN Jr, Lee JJ, El-Naggar AK, Ferris RL, Seethala R, Grandis JR, Chen ZG, Saba NF, Shin DM; Head and Neck Cancer SPORE HIV supplement consortium.

Head Neck. 2017 Dec;39(12):2433-2443. doi: 10.1002/hed.24911. Epub 2017 Sep 25.

PMID:
28945296
21.

Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study.

Kendi AT, Brandon D, Switchenko J, Wadsworth JT, El-Deiry MW, Saba NF, Schuster DM, Subramaniam RM.

Am J Nucl Med Mol Imaging. 2017 Sep 1;7(4):174-180. eCollection 2017.

22.

Refining the predictors of outcome in patients with resectable esophageal cancer.

Saba NF.

Cancer. 2017 Nov 1;123(21):4097-4098. doi: 10.1002/cncr.30952. Epub 2017 Sep 8. No abstract available.

PMID:
28885686
23.

The Impact of Histologic Phenotype in the Treatment of Sinonasal Cancer.

López F, Lund VJ, Suárez C, Snyderman CH, Saba NF, Robbins KT, Vander Poorten V, Strojan P, Mendenhall WM, Rinaldo A, Ferlito A.

Adv Ther. 2017 Oct;34(10):2181-2198. doi: 10.1007/s12325-017-0605-9. Epub 2017 Sep 4. Review.

PMID:
28871554
24.

Adenosquamous Carcinoma of the Esophagus: An NCDB-Based Investigation on Comparative Features and Overall Survival in a Rare Tumor.

Evans M, Liu Y, Chen C, Steuer C, Cassidy R III, Landry J, Higgins K, Beitler JJ, Willingham F, Owonikoko TK, Ramalingam SS, Shin DM, Jegadeesh NK, El-Rayes B, Fernandez F, Krasinskas AM, Gillespie T, Saba NF.

Oncology. 2017;93(5):336-342. doi: 10.1159/000466699. Epub 2017 Aug 24.

PMID:
28848104
25.

Resilience and biomarkers of health risk in Black smokers and nonsmokers.

Berg CJ, Haardörfer R, McBride CM, Kilaru V, Ressler KJ, Wingo AP, Saba NF, Payne JB, Smith A.

Health Psychol. 2017 Nov;36(11):1047-1058. doi: 10.1037/hea0000540. Epub 2017 Aug 21.

PMID:
28825494
26.

Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.

de Bree R, Wolf GT, de Keizer B, Nixon IJ, Hartl DM, Forastiere AA, Haigentz M Jr, Rinaldo A, Rodrigo JP, Saba NF, Suárez C, Vermorken JB, Ferlito A.

Head Neck. 2017 Nov;39(11):2329-2349. doi: 10.1002/hed.24883. Epub 2017 Aug 17. Review.

27.

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.

Harrington KJ, Ferris RL, Blumenschein G Jr, Colevas AD, Fayette J, Licitra L, Kasper S, Even C, Vokes EE, Worden F, Saba NF, Kiyota N, Haddad R, Tahara M, Grünwald V, Shaw JW, Monga M, Lynch M, Taylor F, DeRosa M, Morrissey L, Cocks K, Gillison ML, Guigay J.

Lancet Oncol. 2017 Aug;18(8):1104-1115. doi: 10.1016/S1470-2045(17)30421-7. Epub 2017 Jun 23.

PMID:
28651929
28.

Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy.

Saba NF, Mody MD, Tan ES, Gill HS, Rinaldo A, Takes RP, Strojan P, Hartl DM, Vermorken JB, Haigentz M Jr, Ferlito A.

Crit Rev Oncol Hematol. 2017 Jul;115:50-58. doi: 10.1016/j.critrevonc.2017.04.011. Epub 2017 Apr 27. Review.

PMID:
28602169
29.

Disappearance of the Hemorrhagic Component of the Frontal Contusion Possibly due to Redistribution of the Hematoma within the Subarachnoid Space: A Case Report.

Faheem M, Jaiswal M, Ojha BK, Chandra A, Singh SK, Srivastava C, Saba NU.

Pediatr Neurosurg. 2017;52(4):268-270. doi: 10.1159/000475532. Epub 2017 Jun 10.

PMID:
28601873
30.

Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.

Naik KB, Liu Y, Goodman M, Gillespie TW, Pickens A, Force SD, Steuer CE, Owonikoko TK, Ramalingam SS, Higgins K, Beitler JJ, Shin DM, Willingham FF, El-Rayes B, Landry JC, Fernandez FG, Saba NF.

Cancer. 2017 Sep 15;123(18):3476-3485. doi: 10.1002/cncr.30763. Epub 2017 May 2.

PMID:
28464264
31.

Thermal and dynamic mechanical properties of cellulose nanofibers reinforced epoxy composites.

Saba N, Safwan A, Sanyang ML, Mohammad F, Pervaiz M, Jawaid M, Alothman OY, Sain M.

Int J Biol Macromol. 2017 Sep;102:822-828. doi: 10.1016/j.ijbiomac.2017.04.074. Epub 2017 Apr 25.

PMID:
28455253
32.

Long-term follow-up of patients with multiple myeloma treated with total body irradiation-Melphalan conditioning.

Munker R, Baghian A, Koleva Y, Andrews P, Matharoo GS, Wright AE, Saba NS, Weiner RS, Safah H.

Eur J Haematol. 2017 Jul;99(1):56-59. doi: 10.1111/ejh.12890. Epub 2017 May 3.

PMID:
28370630
33.

How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?

López F, Williams MD, Cardesa A, Hunt JL, Strojan P, Rinaldo A, Nixon IJ, Rodrigo JP, Saba NF, Mendenhall WM, Quer M, Suárez C, Ferlito A.

Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2709-2726. doi: 10.1007/s00405-017-4533-8. Epub 2017 Mar 31. Review.

PMID:
28364287
34.

Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.

Krieger DA, Hudgins PA, Nayak GK, Baugnon KL, Corey AS, Patel MR, Beitler JJ, Saba NF, Liu Y, Aiken AH.

AJNR Am J Neuroradiol. 2017 Jun;38(6):1193-1199. doi: 10.3174/ajnr.A5157. Epub 2017 Mar 31.

35.

Commentary: Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study).

Saba NF.

Front Oncol. 2017 Mar 13;7:31. doi: 10.3389/fonc.2017.00031. eCollection 2017. No abstract available.

36.

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.

Bauml J, Seiwert TY, Pfister DG, Worden F, Liu SV, Gilbert J, Saba NF, Weiss J, Wirth L, Sukari A, Kang H, Gibson MK, Massarelli E, Powell S, Meister A, Shu X, Cheng JD, Haddad R.

J Clin Oncol. 2017 May 10;35(14):1542-1549. doi: 10.1200/JCO.2016.70.1524. Epub 2017 Mar 22.

37.

Otorhinolaryngological Toxicities of New Drugs in Oncology.

Hartl DM, Morel D, Saavedra E, Massard C, Rinaldo A, Saba NF, Ferlito A, Soria JC.

Adv Ther. 2017 Apr;34(4):866-894. doi: 10.1007/s12325-017-0512-0. Epub 2017 Mar 17. Review.

PMID:
28315206
38.

A centrocyte blood count of a quarter million.

Behrens M, Chowdry RP, Saba S, Saba NS.

Am J Hematol. 2017 Sep;92(9):972-973. doi: 10.1002/ajh.24708. Epub 2017 Apr 6. No abstract available.

PMID:
28247462
39.

FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.

Fu Z, Gong Y, Liegl R, Wang Z, Liu CH, Meng SS, Burnim SB, Saba NJ, Fredrick TW, Morss PC, Hellstrom A, Talukdar S, Smith LE.

Cell Rep. 2017 Feb 14;18(7):1606-1613. doi: 10.1016/j.celrep.2017.01.014.

40.

Nasal juvenile angiofibroma: Current perspectives with emphasis on management.

López F, Triantafyllou A, Snyderman CH, Hunt JL, Suárez C, Lund VJ, Strojan P, Saba NF, Nixon IJ, Devaney KO, Alobid I, Bernal-Sprekelsen M, Hanna EY, Rinaldo A, Ferlito A.

Head Neck. 2017 May;39(5):1033-1045. doi: 10.1002/hed.24696. Epub 2017 Feb 15. Review.

PMID:
28199045
41.

Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy.

Sayan M, Cassidy RJ, Switchenko JM, Kayode OA, Saba NF, Steuer CE, Shin DM, Wadsworth JT, El-Deiry M, Patel M, Beitler JJ, Higgins KA.

Front Oncol. 2017 Jan 11;6:272. doi: 10.3389/fonc.2016.00272. eCollection 2016.

42.

Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers.

Cassidy RJ, Switchenko JM, Jegadeesh N, Sayan M, Ferris MJ, Eaton BR, Higgins KA, Wadsworth JT, Magliocca KR, Saba NF, Beitler JJ.

JAMA Otolaryngol Head Neck Surg. 2017 Apr 1;143(4):382-388. doi: 10.1001/jamaoto.2016.3795.

43.

Mechanical, morphological and structural properties of cellulose nanofibers reinforced epoxy composites.

Saba N, Mohammad F, Pervaiz M, Jawaid M, Alothman OY, Sain M.

Int J Biol Macromol. 2017 Apr;97:190-200. doi: 10.1016/j.ijbiomac.2017.01.029. Epub 2017 Jan 9.

PMID:
28082223
44.

Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.

Herndon TM, Chen SS, Saba NS, Valdez J, Emson C, Gatmaitan M, Tian X, Hughes TE, Sun C, Arthur DC, Stetler-Stevenson M, Yuan CM, Niemann CU, Marti GE, Aue G, Soto S, Farooqui MZH, Herman SEM, Chiorazzi N, Wiestner A.

Leukemia. 2017 Jun;31(6):1340-1347. doi: 10.1038/leu.2017.11. Epub 2017 Jan 11.

45.

Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non-Small-Cell Lung Cancer.

Saba NF, Wang Y, Fu H, Koenig L, Khuri FR, Shin DM, Chen ZG.

Clin Lung Cancer. 2017 May;18(3):e203-e210. doi: 10.1016/j.cllc.2016.12.005. Epub 2016 Dec 22.

PMID:
28073681
46.

CT Accuracy of Extrinsic Tongue Muscle Invasion in Oral Cavity Cancer.

Junn JC, Baugnon KL, Lacayo EA, Hudgins PA, Patel MR, Magliocca KR, Corey AS, El-Deiry M, Wadsworth JT, Beitler JJ, Saba NF, Liu Y, Aiken AH.

AJNR Am J Neuroradiol. 2017 Feb;38(2):364-370. doi: 10.3174/ajnr.A4993. Epub 2016 Nov 10.

47.

Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.

Steuer CE, Behera M, Liu Y, Fu C, Gillespie TW, Saba NF, Shin DM, Pillai RN, Pakkala S, Owonikoko TK, Khuri FR, Ramalingam SS.

Clin Lung Cancer. 2017 May;18(3):286-292. doi: 10.1016/j.cllc.2016.11.016. Epub 2016 Dec 7.

PMID:
28043773
48.

Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline.

Wang D, Peng S, Amin AR, Rahman MA, Nannapaneni S, Liu Y, Shin DM, Saba NF, Eichler JF, Chen ZG.

PLoS One. 2016 Dec 29;11(12):e0168450. doi: 10.1371/journal.pone.0168450. eCollection 2016.

49.

ACR appropriateness criteria® nasal cavity and paranasal sinus cancers.

Siddiqui F, Smith RV, Yom SS, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, Ridge JA, Saba NF, Worden F, Yao M, Salama JK; Expert Panel on Radiation Oncology - Head and Neck Cancer.

Head Neck. 2017 Mar;39(3):407-418. doi: 10.1002/hed.24639. Epub 2016 Dec 29. Review.

PMID:
28032679
50.

Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review.

Steuer CE, Behera M, Ernani V, Higgins KA, Saba NF, Shin DM, Pakkala S, Pillai RN, Owonikoko TK, Curran WJ, Belani CP, Khuri FR, Ramalingam SS.

JAMA Oncol. 2017 Aug 1;3(8):1120-1129. doi: 10.1001/jamaoncol.2016.4280. Review.

PMID:
27978552

Supplemental Content

Support Center